Abstract
Acute otitis media (AOM) and viral upper respiratory tract infections (URIs) represent the two most common diseases affecting the human population, and account for substantial patient morbidity and health care costs. Epidemiologic and experimental studies suggest that URIs play a causal role in the pathogenesis of AOM. Specifically, viruses can either invade the middle ear (ME) space and invoke an inflammatory response that culminates in ME effusion formation and consequent symptoms, or URIs might cause eustachian-tube dysfunction, resulting in negative ME pressures and subsequent ME effusion (hydrops ex vacuo theory). The events responsible for the inflammatory response of the human ME following viral exposure have not been well characterized. Although many prophylactic and therapeutic interventions have been evaluated for the treatment of AOM, the information on virusspecific interventions is sparse. In this article, the epidemiology, pathogenesis, diagnosis, and management of viral otitis media are reviewed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Wald ER, Guerra N, Byers C: Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics 1991, 87:129–133.
Teele DW, Klein JO, Rosner B: Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989, 160:83–94.
Stool SE, Field M: The impact of otitis media. Pediatr Infect Dis J 1989, 8:S11-S14.
Rosenfeld RM, Vertrees JE, Carr J, et al.: Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr 1994, 124:355–367.
Dowell SF, Butler JC, Giebink GS, et al.: Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus Pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999, 18:1–9.
Patel JA, Reisner B, Vizirinia N, et al.: Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J Pediatr 1995, 126:799–806.
Bluestone CD, Klein JO: Intratemporal complications and sequelae of otitis media. In Pediatric Otolaryngology. Edited by Bluestone CD, Stool S. Philadelphia: WB Saunders; 1990:489–494.
Arola M, Ziegler T, Ruuskanen O, et al.: Rhinovirus in acute otitis media. J Pediatr 1988, 113:693–695.
Ruuskanen O, Arola M, Putto-Laurila A, et al.: Acute otitis media and respiratory virus infections. Pediatr Infect Dis J 1989, 8:94–99.
Ruuskanen O, Heikkinen T: Otitis media: etiology and diagnosis. Pediatr Infect Dis J 1994, 13:S23-S261.
Vesa S, Kleemola M, BlomQvist S, et al.: Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infec Dis J 2001, 20:574–581.
Heikkinen T, Thint M, Chonmaitree T: Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999, 340:260–264. Detection of respiratory viruses in AOM using modern techniques.
Simoes EA, Groothuis JR, Tristram DA, et al.: Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high-risk children. J Pediatr 1996, 129:214–219.
Heikkinen T, Ruuskanen O, Waris M, et al.: Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991, 145:445–448.
Clements DA, Langdon L, Bland C, et al.: Influenza A vaccine decreases the incidence of otitis media in 6- to 30-monthold children in day care. Arch Pediatr Adolesc Med 1995, 149:1113–1117.
Belshe RB, Mendelman PM, Treanor J, et al.: The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998, 338:1405–1412.
Belshe RB, Gruber WC: Prevention of otitis media in children with live attenuated vaccine given intranasally. Pediatr Infect Dis J 2000, 19:S66-S71. Multicenter clinical trial using live, attenuated influenza vaccine for prevention of OM.
Buchman CA, Doyle WJ, Skoner DP, et al.: Influenza A virus-induced acute otitis media. J Infect Dis 1995, 172:1348–1351.
Buchman CA, Doyle WJ, Skoner D, et al.: Comparison of the nasal and otologic responses following intranasal challenge with influenza A virus and rhinovirus type 39. In Recent Advances in Otitis Media. Edited by Lim DJ, Bluestone CD, Casselbrant M, et al. Hamilton Ontario: BC Decker; 1996: 431–433.
Buchman CA, Doyle WJ, Pilcher O, et al.: Nasal and otologic effects of experimental respiratory syncytial virus infection in adults. Am J Otolaryngol 2002, 23:70–75.
Chonmaitree T: Viral and bacterial interaction in acute otitis media. Pediatr Infect Dis J 2000, 19:S24-S30. Review of the role of viruses and bacteria in AOM.
Rayner MG, Zhang Y, Gorry MC, et al.: Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998, 279:296–299.
Winther B, Hayden FG, Arruda E: Viral respiratory infection in schoolchildren: effects on middle-ear pressure. Pediatrics 2002, 109:826–832.
Alper CM, Doyle WJ, Skoner DP, et al.: Prechallenge antibodies moderate disease expression in adults experimentally exposed to rhinovirus strain hanks. Clin Infect Dis 1998, 27:119–128.
Doyle WJ, Alper CM, Buchman CA, et al.: Illness and otologic changes during upper respiratory virus infection. Laryngoscope 1999, 109:324–328.
Bakaletz LO, Daniels RL, Lim DJ: Modeling adenovirus type 1-induced otitis media in the chinchilla: effect on ciliary activity and fluid transport function of eustachian tube mucosal epithelium. J Infect Dis 1993, 168:865–872.
Chung MH, Griffith SR, Park KH, et al.: Cytological and histological changes in the middle ear after inoculation of influenza A virus. Acta Otolaryngol (Stockh) 1993, 113:81–87.
Park KH, Bakaletz LO, Coticchia J, et al.: Effect of influenza A virus infection on ciliary activity and dye transport function in the chinchilla ET. Ann Otol Rhinol Laryngol 1993, 102:551–553.
Suzuki K, Bakaletz LO: Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect Immun 1994, 62:1710–1718.
Miyamoto N, Bakaletz LO: Kinetics of the ascension of NTHi from the nasopharynx to the middle ear coincident with adenovirus-induced compromise in the chinchilla. Microb Pathog 1997, 23:119–126.
Bakaletz LO, Murwin DM, Billy JM: Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect Immun 1995, 63:4188–4190.
Chonmaitree T, Henrickson KJ: Detection of respiratory viruses in the middle ear fluids of children with acute otitis media by multiplex reverse transcription-polymerase chain reaction assay. Pediatr Infect Dis J 2000, 19:258–260.
Tong HH, Grants I, Liu X, et al.: Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with of without antecedent influenza A virus infection. Infect Immun 2002, 70:4292–4301.
Hirano T, Kurono Y, Ichimiya I, et al.: Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization. Otolaryngol Head Neck Surg 1999, 121:616–621.
Williams RL, Chalmers TC, Stange KC, et al.: Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion: a meta-analytic attempt to resolve the brouhaha. JAMA 1993, 270:1344–1351.
Mossad SB: Treatment of the common cold. BMJ 1998, 317:33–36.
Turner R: The treatment of rhinovirus infections: progress and potential. Antivir Res 2001, 49:1–14.
Ruohola A, Heikkinen T, Waris M, et al.: Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children. J Allergy Clin Immunol 2000, 106:467–471.
Marchisio P, Cavagna R, Maspes B, et al.: Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 2002, 35:168–174.
Kneyber MC, Kimpen JL: Current concepts on active immunization against respiratory syncytial virus for infants and young children. Pediatr Infect Dis J 2002, 21:685–696.
Crowe JE: Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine 1998, 16:1423–1432.
Hayden K, Andries K, Janssen PA: Safety and efficacy of intranasal pirodavir in experimental rhinovirus infection. Antimicrob Agents Chemother 1992, 36:727–732.
Sperber SJ, Doyle WJ, McBride TP, et al.: Otologic effects of interferon beta serine in experimental rhinovirus colds. Arch Otolaryngol Head Neck Surg 1992, 118:933–936.
Hayden FG: Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention. Vaccine 2000, 19(Suppl1):S66-S70.
Doyle WJ, Skoner DP, Alper CM, et al.: Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (dH1N1) virus. J Infect Dis 1998, 177:1260–1265.
Walker JB, Hussey EK, Treanor JJ, et al.: Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. J Infect Dis 1997, 176:1417–1422.
Whitley RJ, Hayden FG, Reisinger KS, et al.: Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001, 20:127–133.
Casselbrant ML, Kaleida PH, Rockette HE, et al.: Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J 1992, 11:278–286.
Paradise JL, Bluestone CD, Rogers KD, et al.: Efficacy of adenoidectomy for recurrent otitis media in children previously treated with tympanostomy-tube placement: results of parallel randomized and nonrandomized trials. JAMA 1990, 18:263:2066–2073.
Rosenfeld RM: Natural history of untreated otitis media. In Evidence-Based Otitis Media. Edited by Rosenfeld RM, Bluestone CD. Hamilton, Ontario: BC Decker; 1999:157–177.
Rosenfeld RM, Vertrees JE, Carr J, et al.: Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr 1994, 124:355–367.
Del Mar C, Glasziou P, Hayem M: Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 1997, 314:1526–1529.
Butler CC, van Der Voort JH: Steroids for otitis media with effusion: a systematic review. Arch Pediatr Adolesc Med 2001, 155:641–647.
Flynn CA, Griffin G, Tudiver F: Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev 2002, 1:CD001727.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buchman, C.A., Brinson, G.M. Viral otitis media. Curr Allergy Asthma Rep 3, 335–340 (2003). https://doi.org/10.1007/s11882-003-0094-6
Issue Date:
DOI: https://doi.org/10.1007/s11882-003-0094-6